Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

MGK: I fear you may be right about the FDA requiri

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153767
(Total Views: 538)
Posted On: 07/24/2023 11:00:32 AM
Posted By: Jake2212
Re: MGK_2 #135939
MGK: I fear you may be right about the FDA requiring a new HIV trial to reestablish safety for LL. I have to admit that the biggest flaw in my accelerated approval scenario related to requests for benefit risk assessments and HIV clinical trial protocols would be the assumption of FDA assistance in making LL available to the HIV MDR patients in need, while your scenario of the agency requiring a new phase 1 safety trial would effectively get LL's HIV clinical status back to 2015 would be entirely consistent with the agency's history of delaying LL whenever possible.

While the theory that the FDA was demanding submission of a HIV trial protocol just out of idle curiosity always seemed (at least to me) a stretch even by FDA standards, while your theory, which would likely result in an even longer delay in getting the hold lifted, does seem much more plausible, notwithstanding that I could not find a precedent for the agency requiring a biotech to start over in demonstrating the safety of a drug which had already completed multiple trials in various phases.

Anyway, we'll all be put out of our misery soon, at least from a curiosity point of view. I'm still clinging to a thread of hopefulness that there is a sane explanation for the risk assessment/protocol gymnastics, but I am definitely worried that the FDA has likely stayed true to form.


(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us